Skip to main content
. Author manuscript; available in PMC: 2020 Aug 23.
Published in final edited form as: Vaccine. 2019 Aug 1;37(36):5177–5184. doi: 10.1016/j.vaccine.2019.07.074

Table 2. Effect of maternal ART treatment on transfer of nAb from mother to infant.

For each MIP, the percent neutralization of the infant was divided by that of the cognate mother. The average of those ratios is reported for ART positive mothers (Column 2) versus negative (Column 3). Differences in the average of ratios based on treatment status was statistically evaluated using non-parametric Mann-Whitney tests. A significant difference based on ART treatment status was evident only against Ad5.

Adenovirus ART+ ART− Significance P-Value
Ad4 0.47 0.45 ns 0.799
Ad5 0.97 0.80 * 0.021
Ad7 0.79 0.72 ns 0.903
Ad26 0.88 0.89 ns 0.249
Ad28 0.69 0.59 ns 0.217
Ad45 0.65 0.63 ns 0.562
Ad48 0.69 0.60 ns 0.411
*

P ≤ 0.05